Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors

NCT04110223 is registered in ClinicalTrials.gov with Shandong Cancer Hospital and Institute as lead sponsor.

NCT NCT04110223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04110223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors
Lead sponsor
Shandong Cancer Hospital and Institute
Phase
Observational
Overall status
Unknown status
Start date
October 8, 2018
Completion date
October 8, 2021
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, radiation toxicity, radiosensitivity